We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Genomic Study Identifies Risk Regions for Intrahepatic Cholestasis of Pregnancy

By LabMedica International staff writers
Posted on 20 Jun 2026

Intrahepatic cholestasis of pregnancy (ICP) affects 0. More...

2–2% of pregnancies and typically arises after 30 weeks, presenting with intense itching of the palms and soles. Diagnosis is confirmed by elevated liver enzymes and increased serum bile acids, and the condition is linked to higher risks of preterm birth and stillbirth. Although genetic susceptibility has been suspected, the underlying mechanisms have been unclear. New findings demonstrate that large-scale human genetic analyses have identified multiple regions associated with ICP.

Tampere University led an international genome-wide meta-analysis that combined genetic data from more than 4,700 women with a history of ICP and over 436,000 control women from Finland, Iceland, Estonia and Denmark. The study identified 26 genetic regions associated with ICP, including 10 not previously reported. Genes within these regions influence hepatic handling of bile acids, fats and cholesterol, aligning ICP susceptibility with broader disturbances in liver metabolism during pregnancy-related hormonal changes.

The investigators also examined clinical associations beyond pregnancy. Women with prior ICP showed an increased risk of hepatobiliary disorders, including fatty liver disease, gallstones and inflammation of the bile ducts, as well as higher rates of certain autoimmune diseases such as Crohn’s disease, thyroid disorders and type 2 diabetes. Analyses further suggested a possible shared genetic basis between ICP and pancreatitis.

The findings were published in Nature Communications on May 25, 2026. According to the study authors, the results hold promise for identifying at‑risk groups, improving diagnosis and treatment, and supporting the early identification of related conditions. The work involved researchers affiliated with Tampere University and the University of Oulu.

"Our analyses also suggested a possible shared genetic basis between ICP and pancreatitis, which is inflammation of the pancreas, meaning that the same genetic susceptibility may increase the risk of both conditions. This is a new discovery that, to our knowledge, has not been reported previously. However, further studies are needed to better understand this connection," said Jaakko Tyrmi, postdoctoral research fellow at Tampere University and the University of Oulu.

Related Links
Tampere University


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Automated Clinical Chemistry Analyzer
Envoy 500+
New
Automated Coagulation Analyzer
Hemolumi H6
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Immunology

view channel
Image:Proteomic tear-fluid analysis revealed abnormal patterns in proteins that regulate nerves and T cells in individuals with eye problems (Image Credit: Adobe Stock)

Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more

Industry

view channel
Photo courtesy of Natera

Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.